↓ Skip to main content
What is this page? Embed badge

Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china

Overview of attention for article published in Cost Effectiveness and Resource Allocation, February 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog
twitter
2 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
20 Mendeley
Summary Blogs X Dimensions citations
So far, Altmetric has seen 1 blog post.

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.